ClinicalTrials.Veeva

Menu

Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma

A

Assiut University

Status

Completed

Conditions

Chorioretinal Changes
Visual Field
Primary Open Angle Glaucoma
OCT Angiography

Treatments

Other: Control group
Other: POAG group

Study type

Observational

Funder types

Other

Identifiers

NCT06978101
MD/AZ.AST./OPH026/10/191/1/202

Details and patient eligibility

About

This study aimed to assess the correlation between visual field changes and optical coherence tomography (OCT) angiography changes of retinal nerve fiber layer in patients with primary open angle glaucoma.

Full description

Glaucoma is the leading cause of irreversible blindness worldwide. Since glaucomatous damage is preventable but irreversible, an early diagnosis and close follow-up of glaucoma patients are primordial. Optical coherence tomography angiography (OCTA) is a recently developed, noninvasive imaging modality that detects blood flow through the motion contrast generated by red blood cells.

Currently, there are 2 groups of complementary exams used for the diagnosis and follow-up of glaucoma patients: structural (where OCT has a considerable role) and functional (visual field) optic nerve measurements, Both technologies have strengths and limitations.

A new technology for diagnosis and follow-up that can avoid the limitations summarized above is lacking. OCTA seems to be a good candidate for such a role, OCT can detect the Doppler frequency shift of the backscattered light that provides information on blood flow.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary open angle glaucoma patients.

Exclusion criteria

  1. Hazy media.

  2. Diabetic Retinopathy.

  3. Uveitis.

  4. Other Glaucomas

    • Acute congestive glaucoma
    • Secondary glaucomas

Trial design

100 participants in 2 patient groups

POAG group
Description:
Patients had intraocular pressure (IOP)\>21 mmHg,
Treatment:
Other: POAG group
Control group
Description:
Patients without family history of primary open-angle glaucoma (POAG), IOP ˂21mm Hg.
Treatment:
Other: Control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems